{
  "resourceType" : "MedicationStatement",
  "id" : "mii-exa-onko-medikation-imatinib-atc-version-transition",
  "meta" : {
    "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie-medikation|2027.0.0-ballot.1"]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement mii-exa-onko-medikation-imatinib-atc-version-transition</b></p><a name=\"mii-exa-onko-medikation-imatinib-atc-version-transition\"> </a><a name=\"hcmii-exa-onko-medikation-imatinib-atc-version-transition\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-onko-systemische-therapie-medikation.html\">MII PR Onkologie Systemische Therapie Medikation</a> version: 2027.0.0-ballot.1</p></div><p><b>basedOn</b>: <a href=\"CarePlan-mii-exa-onko-tumorkonferenz-01.html\">CarePlan: identifier = Tumorkonferenz_1; status = active; intent = plan; category = postoperative Tumorkonferenz (Planung der postoperativen Therapie, z. B. zur Frage adjuvante Therapie); created = 2024-01-11</a></p><p><b>partOf</b>: <a href=\"Procedure-mii-exa-onko-systemische-therapie-1.html\">Procedure Chemotherapie</a></p><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/atc L01XE01}, {http://fhir.de/CodeSystem/bfarm/atc L01EA01}\">Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)</span></p><p><b>subject</b>: <a href=\"Patient-example.html\">Erika Beispiel  Female, DoB: 1965-04-12</a></p><p><b>effective</b>: 2020-12-01 --&gt; 2024-08-30</p><p><b>note</b>: </p><blockquote><div><p>CML-Protokoll mit Imatinib</p>\n</div></blockquote></div>"
  },
  "basedOn" : [{
    "reference" : "CarePlan/mii-exa-onko-tumorkonferenz-01"
  }],
  "partOf" : [{
    "reference" : "Procedure/mii-exa-onko-systemische-therapie-1"
  }],
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [{
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "version" : "2020",
      "code" : "L01XE01",
      "display" : "Imatinib"
    },
    {
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "version" : "2021",
      "code" : "L01EA01",
      "display" : "Imatinib"
    }],
    "text" : "Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)"
  },
  "subject" : {
    "reference" : "Patient/example"
  },
  "effectivePeriod" : {
    "start" : "2020-12-01",
    "end" : "2024-08-30"
  },
  "note" : [{
    "text" : "CML-Protokoll mit Imatinib"
  }]
}